APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 217 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $235,848 | -84.8% | 6,200 | -63.5% | 0.00% | -66.7% |
| Q2 2023 | $1,548,700 | -70.3% | 17,000 | -78.5% | 0.00% | -72.7% |
| Q1 2023 | $5,210,114 | -47.0% | 78,989 | -58.4% | 0.01% | -31.2% |
| Q4 2022 | $9,829,037 | +86.5% | 190,080 | +146.4% | 0.02% | +100.0% |
| Q3 2022 | $5,269,000 | -36.6% | 77,153 | -58.0% | 0.01% | 0.0% |
| Q2 2022 | $8,309,000 | +9.0% | 183,763 | +22.5% | 0.01% | +100.0% |
| Q1 2022 | $7,623,000 | +39.2% | 150,010 | +29.5% | 0.00% | 0.0% |
| Q4 2021 | $5,477,000 | -6.3% | 115,836 | -34.7% | 0.00% | -20.0% |
| Q3 2021 | $5,844,000 | -69.8% | 177,344 | -42.0% | 0.01% | -72.2% |
| Q2 2021 | $19,333,000 | +2158.5% | 305,914 | +1067.9% | 0.02% | +1700.0% |
| Q2 2020 | $856,000 | -17.9% | 26,193 | -32.7% | 0.00% | 0.0% |
| Q1 2020 | $1,042,000 | +110.5% | 38,896 | +140.9% | 0.00% | – |
| Q4 2019 | $495,000 | +1275.0% | 16,144 | +861.0% | 0.00% | – |
| Q4 2017 | $36,000 | – | 1,680 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 2,503,059 | $170,959,000 | 29.50% |
| ACUTA CAPITAL PARTNERS, LLC | 554,000 | $37,838,000 | 16.29% |
| Avoro Capital Advisors LLC | 10,125,000 | $691,538,000 | 12.78% |
| Sio Capital Management, LLC | 507,700 | $34,676,000 | 11.02% |
| Logos Global Management LP | 1,300,000 | $88,790,000 | 10.92% |
| EcoR1 Capital, LLC | 5,183,431 | $354,028,000 | 10.45% |
| Cormorant Asset Management, LP | 1,478,000 | $100,947,000 | 7.06% |
| Finepoint Capital LP | 266,090 | $18,174,000 | 5.98% |
| Ghost Tree Capital, LLC | 275,000 | $18,783,000 | 5.27% |
| Boxer Capital, LLC | 1,303,700 | $89,043,000 | 5.01% |